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For humans a daily intake of up to 500 mg omega-3 (n-3) long-chain polyunsaturated fatty acids
(LC-PUFA) is recommended, amounting to an annual requirement of 1.25 million metric tonnes (mt) for a
population of 7 billion people. The annual global supply of n-3 LC-PUFA cannot meet this level of
requirement and so there is a large gap between supply and demand. The dietary source of n-3 LC-PUFA,
fish and seafood, is increasingly provided by aquaculture but using fish oil in feeds to supply n-3 LC-PUFA is
unsustainable. Therefore, new sources of n-3 LC-PUFA are required to supply the demand from aquaculture
and direct human consumption. One approach is metabolically engineering oilseed crops to synthesize n-3
LC-PUFA in seeds. Transgenic Camelina sativa expressing algal genes was used to produce an oil containing
n-3 LC-PUFA to replace fish oil in salmon feeds. The oil had no detrimental effects on fish performance,
metabolic responses or the nutritional quality of the fillets of the farmed fish.
O
mega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA) are essential or conditionally essential
dietary nutrients for vertebrates with well-established health benefits in humans1. Specifically, n-3 LC-
PUFA including eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) have
key roles in neural development, immune and inflammatory responses, and beneficial effects in several patho-
logical conditions, including cardiovascular and neurological diseases, and some cancers2–8. The International
Society for the Study of Fatty Acids and Lipids recommends a daily intake of 500 mg of n-3 LC-PUFA (EPA 1
DHA) for optimum cardiovascular health9 and, projecting this to a population of 7 billion, this amounts to a total
annual requirement for over 1.25 million metric tonnes (mt) of n-3 LC-PUFA. The annual global supply of fish
and fish oil cannotmeet this level of requirement for n-3 LC-PUFA and so there is a large gap between supply and
demand10.
Microalgae in the marine and aquatic environments are the primary producers of the vast majority of n-3 LC-
PUFA11, which accumulate in themarine food web and thus fish and seafood are the predominant source of these
essential nutrients in the diet12. However, global fisheries are at, or beyond, exploitable limits and cannot increase
to satisfy the growing demand for fish and seafood13 and, therefore, around 50% is now farmed14. Paradoxically,
high levels of n-3 LC-PUFA in farmed fish and shrimpwas only assured by the use of fishmeal and, especially, fish
oil, themselves finite and limited marine resources derived from wild fisheries15–17. The only biological alter-
natives to fish oil, vegetable oils, do not contain n-3 LC-PUFA as this biosynthetic pathway is not present in
terrestrial plants18. Therefore, as demand for fish and seafood increases, so will that of n-3 LC-PUFA and, as
supplies are finite10, the gap between the two will only continue to increase in the future.
The only sustainable solution to the ever-increasing global demand for n-3 LC-PUFA is de novo production of
entirely new sources19. This requires the application of modern biotechnology ranging from genetic modification
through to synthetic biology to introduce the n-3 LC-PUFA biosynthesis trait into appropriate oleaginous plat-
forms20–21. This has been applied to produce EPA in the yeast Yarrowia lipolytica22, and DHA in the diatom
Phaeodactylum tricornutum that normally produces only EPA23. However, oilseed crops dominate world oil
production and there is a highly organised and well-established infrastructure for the cultivation, harvest,
processing, distribution, marketing and utilisation of vegetable oils24. Therefore, a highly practical approach to
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developing a novel, renewable supply of n-3 LC-PUFA is the meta-
bolic engineering of oilseed crops with the capacity to synthesize
these bioactive fatty acids in seeds25–26. Production of EPA and
DHA in seeds was initially demonstrated in the model plant
Arabidopsis27–28, and was recently reported in an oilseed crop,
Camelina sativa29–30. C. sativa or false flax, is a member of the
Brassicaceae family and an ancient oilcrop that in the wild type
produces an oil with up to 45% of fatty acids as a-linolenic acid
(LNA; 18:3n-3)31.
In the present study, C. sativa was transformed with a suite of five
microalgal genes to produce a higher plant source of n-3 LC-PUFA30.
The extracted seed oil, containing 20% of total fatty acids as EPA, was
investigated as a replacement for marine fish oil in feeds for Atlantic
salmon (Salmo salar). Triplicate groups of salmon were fed one of
three experimental diets containing fish oil (FO), wild-type Camelina
oil (WCO) or EPA-Camelina oil (ECO) as the sole added lipid source
for 7-weeks. The results showed that growth performance, feed effi-
ciency, fish health and nutritional quality in terms of EPA 1 DHA
for the human consumer were all unaffected by replacing FO with
ECO. Metabolic analysis confirmed the EPA to DHA pathway was
active in liver and transcriptomic analysis indicated that the
EPA:DHA ratio had greater influence on gene expression than abso-
lute level of EPA. This translational research has demonstrated that
n-3-LC-PUFA enriched oils from transgenic oilseed crops can be
effective substitutes for fish oil in feeds for Atlantic salmon, capable
of maintaining n-3 LC-PUFA levels in farmed fish. Thus, oils
extracted from modified oilseed crops represent a potential solution
to supplying the growing demand for these critically important diet-
ary nutrients.
Results
Seeds from transgenic Camelina sativa effectively accumulated
over 20% of EPA. The analysis of fatty acid composition of the oil
(abbreviated to Tr-CO, for transgenic Camelina oil) extracted from
the seeds of transgenic Camelina demonstrated accumulation of
significant levels of EPA (.20%; Table 1), as high as those found
in many fish oils. This increased the total n-3 PUFA content of Tr-
CO to a level similar to fish oil and was accompanied by a reduction
in 18:3n-3 compared to the wild-type Camelina oil (Wt-CO). As
expected, no DHA was detected in the terrestrial-origin oils.
Monoenoic fatty acids, particularly 18:1n-9 and 20:1n-9 were
reduced in Tr-CO compared to Wt-CO, but total n-6 PUFA were
increased due to the increased percentages of 18:3n-6, 20:3n-6 and
arachidonic acid (ARA; 20:4n-6).
Fatty acid compositions of feeds reflected the lipid source utilised
in the formulations. In general terms, the vegetable oil-based feeds,
WCO and ECO, had decreased proportions of saturated fatty acids
(especially 14:0 and 16:0), 16:1n-7, 18:1n-7 and n-3 PUFA (18:4n-3,
22:5n-3 and 22:6n-3) and increased levels of 18:3n-3, 20:1n-9, 18:2n-
6, 20:2n-6 and total n-6 PUFA compared to the FO feed (Table 1).
Furthermore, the ECO feed had increased percentages of n-3 PUFA
(20:4n-3, 20:5n-3), n-6 PUFA (18:2n-6, 18:3n-6, 20:3n-6, and 20:4n-
6) and saturated fatty acids, and decreased monounsaturated fatty
acids (18:1n-9, 20:1n-9) in the ECO feed compared to theWCO feed
(Table 1). In particular, the ECO feed displayed an EPA level of
almost 19% of total fatty acids, similar to that of FO (,16%),
whereas EPA content in the WCO feed was just over 2%, being
derived from fishmeal employed in the formulation of the
Table 1 | Fatty acid composition (percentage of fatty acids) of the oils and feeds
Oils Feeds
Fish Wt-CO Tr-CO FO WCO ECO
14:0 7.50 0.06 n.d. 7.20 1.16 1.30
16:0 17.98 5.14 6.65 18.96 7.79 9.03
18:0 3.56 2.63 5.57 3.72 2.70 4.64
20:0 0.22 1.58 2.37 0.21 1.22 2.06
S saturated1 29.91 9.86 15.54 30.69 13.20 17.38
16:1n-7 8.90 0.12 1.78 7.96 1.30 1.25
18:1n-9 7.70 17.35 6.36 9.84 16.10 6.10
18:1n-7 3.07 1.09 0.00 3.30 2.24 1.85
20:1n-9 1.40 14.69 7.78 2.47 12.72 6.68
22:1n-11 1.02 2.55 0.96 2.34 3.45 1.84
Smonounsaturated2 22.77 36.39 16.88 26.58 36.42 18.22
18:2n-6 1.21 19.26 19.80 3.60 17.23 19.12
18:3n-6 0.31 0.00 1.77 0.25 0.05 1.61
20:2n-6 0.14 1.53 1.84 0.16 1.23 1.21
20:3n-6 0.20 0.00 1.19 0.07 0.00 1.19
20:4n-6 0.98 0.06 2.86 0.88 0.13 2.54
S n-6 PUFA3 3.30 20.85 27.46 5.28 18.65 25.72
18:3n-3 0.85 31.88 11.17 1.01 24.96 10.45
18:4n-3 3.18 0.00 1.00 2.45 0.44 1.40
20:3n-3 0.08 1.01 1.35 0.07 0.76 0.97
20:4n-3 0.81 0.00 3.30 0.66 0.10 3.00
20:5n-3 18.76 0.00 20.36 15.95 2.14 18.75
22:5n-3 2.15 0.00 1.42 1.81 0.27 1.02
22:6n-3 12.35 0.00 0.00 11.23 2.50 2.42
S n-3 PUFA 38.20 32.89 38.60 33.19 31.17 38.03
S PUFA4 47.32 53.74 66.06 42.73 50.38 64.40
Total n-3 LC-PUFA 34.05 0.00 25.08 29.55 5.01 25.19
Data expressed as means of three technical replicates per batch of diet.
1contains 15:0, 22:0 and 24:0;
2contains 16:1n-9, 20:1n-11, 20:1n-7, 22:1n-9 and 24:1n-9;
3contains 22:4n-6 and 22:5n-6;
4contains C16 PUFA. Fish and FO, fish oil and respective feed; LC- PUFA, long-chain polyunsaturated fatty acid (sum of 20:4n-3, 20:5n-3 22:5n-3 and 22:6n-3); n.d. not detected; Tr-CO and ECO, oil from
transgenic Camelina and respective feed; Wt-CO and WCO, oil from wild-type Camelina and respective feed.
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experimental feeds. Furthermore, around 2.5% DHA was present in
both WCO and ECO feeds (as a result of the addition of fishmeal).
There was no difference in growth performance and feed
efficiency between fish fed ECO and FO. At the end of the trial,
fish from all dietary treatments more than doubled their weight and
there were no mortalities (Table 2). There were no significant
differences in final weight, total length or specific growth rate
between fish fed the different diets. Other fish performance and
basic health indicators such as hepatosomatic and viscerosomatic
index (HSI and VSI respectively) and Fulton’s condition factor (k)
were unaffected. Feed intake and feed efficiency, as determined by
feed conversion ratio, were also not affected by dietary treatment
(Table 2). Proximate analysis of whole fish showed that fish fed the
ECO diet had similar protein, dry matter and ash compositions to
fish fed the FOdiet, but lipid contents were higher in fish fed the ECO
and WCO diets compared to FO-fed fish (Table 3). Fish muscle
(flesh) lipid content was not affected by diet (Table 4), but liver
total lipid content was higher in fish fed WCO diet than in fish fed
FO or ECO diets (Table 5). The higher lipid content in fish fed the
WCO diet was associated with increased triacylglycerol (TAG)
content (Supplementary Table 1). However, the increased liver
lipid deposition was not reflected in higher HSI (Table 2).
Fatty acid composition of muscle tissue from ECO-fed fish
reflected dietary fatty acids. The fatty acid profile of muscle tissue
(flesh) of fish fed the ECO diet reflected the dietary fatty acid content
(Table 4). Therefore, flesh of fish fed the ECO diet had a higher EPA
level than fish fed both FO and WCO diets. Similarly, the level of
docosapentaenoic acid (DPA; 22:5n-3) in flesh of ECO-fed fish was
similar to that found in FO-fed fish. The levels of DHA in flesh were
not influenced by dietary EPA, and reflected dietary DHA contents
with similar levels found between fish fed ECO andWCOdiets. Total
n-3 LC-PUFA (20:4n-3 1 EPA 1 DPA 1 DHA) was higher in fish
fed the ECO diet (23.8%) than in fish fed WCO (12.6%), but lower
than in FO-fed fish (29.3%). Total saturated fatty acids in flesh of fish
fed the ECO diet were intermediate between the levels in fish fed the
FO and WCO diets, which were higher and lower, respectively.
However, monounsaturated fatty acid content was lowest in fish
fed the ECO diet, and total n-6 PUFA levels of flesh were higher in
fish fed both vegetable oil diets (WCO and ECO) compared to fish
fed the FO diet, reflecting dietary levels.
High DHA levels in liver of fish fed the ECO diet indicated active
DHA biosynthesis. Similar to muscle tissue, the EPA level in liver of
fish fed the ECO diet was higher than in fish fed either of the other
diets (Table 5). However, in contrast tomuscle, DPA level in liver was
also highest in fish fed the ECO diet compared to fish fed either the
FO or WCO diets. Furthermore, liver DHA contents differed
significantly, being higher in liver of ECO-fed fish than in liver of
fish fed WCO, but lower than in fish fed FO. The higher DPA and
DHA levels in liver of ECO-fed fish compared to those in livers of
WCO-fed fish suggested active biosynthesis and accumulation of
these fatty acids in fish fed the high EPA feed. In contrast, the
highest percentages of metabolites derived from 18:3n-3 (18:4n-3,
20:3n-3 or 20:4n-3) were observed in liver of fish fed WCO. There
was higher n-6 PUFA in livers of fish fed both the vegetable oil diets
Table 2 | Growth performance, survival, feed utilisation and basic
biometry over the 7-week experimental period
FO WCO ECO
Final weight (g) 196.5 6 26.3 200.5 6 28.5 207.9 6 26.5
Total length (cm) 25.0 6 1.0 24.8 6 1.4 25.0 6 1.0
Survival (%) 100.0 6 0.0 100.0 6 0.0 100.0 6 0.0
HSI 0.9 6 0.1 0.9 6 0.1 0.9 6 0.1
VSI 9.5 6 0.9 9.6 6 1.2 9.9 6 0.7
FI (g/tank) 4200.0 6 155.0 4203.0 6 97.0 4257.0 6 216.0
FCR 0.9 6 0.0 0.9 6 0.0 0.9 6 0.0
SGR 1.9 6 0.0 1.9 6 0.0 2.0 6 0.1
k 1.3 6 0.0 1.3 6 0.0 1.3 6 0.0
Data are means 6 SD (n 5 3). There were no significant differences between treatments in any
parameter. FCR, feed conversion ratio; FI, feed intake; HSI, hepato-somatic index; k, condition
factor; SGR, specific growth rate; VSI, viscera-somatic index.
Table 3 | Whole body proximate composition (%) at initiation of the
dietary trial and after 7 weeks of feeding the experimental diets
Initial FO WCO ECO
Dry matter 28.4 6 1.2 29.8 6 0.3b 30.7 6 0.4a 30.3 6 0.1ab
Protein 17.8 6 0.5 17.5 6 0.0 17.5 6 0.2 17.3 6 0.1
Lipid 8.0 6 0.2 9.7 6 0.2b 10.6 6 0.3a 10.4 6 0.1a
Ash 2.2 6 0.6 2.0 6 0.0 1.9 6 0.0 1.9 6 0.1
Data are means 6 SD (n 5 3). Different superscript letters within a row denote significant
differences among diets. Statistical differences between dietary treatment only (not initial) were
determined by one-way ANOVA with Tukey’s comparison test (p , 0.05).
Table 4 | Lipid content (percentage of wet weight) and fatty acid
compositions (percentage of total fatty acids) of total lipid from
muscle tissue (flesh) of Atlantic salmon after 7 weeks of feeding
the experimental diets
FO WCO ECO
Lipid content 3.3 6 0.3 3.9 6 0.1 3.2 6 0.4
14:0 5.0 6 0.1a 1.6 6 0.1b 1.7 6 0.0b
16:0 17.3 6 0.1a 11.0 6 0.1c 12.1 6 0.1b
18:0 3.8 6 0.0b 3.4 6 0.1b 4.6 6 0.1a
20:0 0.2 6 0.0c 0.8 6 0.0b 1.1 6 0.0a
Total saturated1 26.9 6 0.3a 17.3 6 0.2c 20.0 6 0.2b
16:1n-7 6.1 6 0.1a 1.9 6 0.0b 2.0 6 0.1b
18:1n-9 14.8 6 0.3b 19.1 6 0.6a 13.7 6 0.6b
18:1n-7 3.9 6 0.4a 2.4 6 0.3b 2.4 6 0.0b
20:1n-11 0.3 6 0.0a 0.2 6 0.0b 0.2 6 0.0ab
20:1n-9 2.6 6 0.1c 8.5 6 0.2a 4.7 6 0.0b
20:1n-7 0.3 6 0.0b 0.3 6 0.0a 0.3 6 0.0a
22:1n-11 1.9 6 0.2 1.6 6 0.1 1.7 6 0.1
22:1n-9 0.3 6 0.0c 1.3 6 0.0a 0.6 6 0.0b
Total monoenes2 31.0 6 0.5b 36.1 6 0.6a 26.4 6 0.6c
18:2n-6 5.2 6 0.1c 13.3 6 0.0b 14.5 6 0.1a
18:3n-6 0.2 6 0.0c 0.3 6 0.0b 0.7 6 0.0a
20:2n-6 0.5 6 0.0c 1.4 6 0.0b 1.7 6 0.0a
20:3n-6 0.3 6 0.0c 0.5 6 0.0b 1.3 6 0.0a
20:4n-6 0.9 6 0.0b 0.4 6 0.0c 1.7 6 0.0a
Total n-6 PUFA3 7.5 6 0.2c 16.1 6 0.1b 20.2 6 0.0a
18:3n-3 1.8 6 0.0c 14.6 6 0.2a 7.1 6 0.1b
18:4n-3 1.4 6 0.0b 2.0 6 0.1a 1.1 6 0.0b
20:3n-3 0.2 6 0.0b 1.0 6 0.0a 0.9 6 0.0a
20:4n-3 1.1 6 0.1b 1.1 6 0.0b 2.4 6 0.0a
20:5n-3 9.3 6 0.3b 2.9 6 0.1c 10.2 6 0.4a
22:5n-3 3.1 6 0.1a 0.9 6 0.0b 3.0 6 0.1a
22:6n-3 15.8 6 0.9a 7.7 6 0.5b 8.2 6 0.1b
Total n-3 PUFA 32.7 6 0.9a 30.2 6 0.8b 33.0 6 0.6a
Total PUFA4 42.2 6 0.7c 46.6 6 0.8b 53.6 6 0.6a
Total n-3 LC-PUFA 29.3 6 0.9a 12.6 6 0.7c 23.8 6 0.6b
Data expressed as means 6 SD (n 5 3). Different superscript letters within a row denote significant
differences among diets. Statistical differences were determined by one-way ANOVA with Tukey’s
comparison test (p , 0.05).
1contains 15:0, 22:0 and 24:0;
2contains 16:1n-9 and 24:1n-9;
3contains 22:4n-6 and 22:5n-6;
4contains C16 PUFA. ECO, feed containing oil from transgenic Camelina; FO, fish oil feed; LC-
PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3);
WCO, feed containing oil from wild-type Camelina.
www.nature.com/scientificreports
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compared to fish fed FO with 18:2n-6 being highest in fish fedWCO
and ARA being highest in fish fed ECO. In absolute terms (mg of
fatty acid per 100 g of tissue), EPA and DPA content were higher in
ECO-fed fish than in fish fed the other dietary treatment. Overall, in
absolute terms, liver of fish fed the ECO diet showed no significant
difference in total n-3 PUFA content compared to fish fed FO
(Supplementary Table 1).
The vegetable oil diets induced a similar number of differentially
expressed genes compared to FO. Microarray analysis of liver
transcriptomes returned 2228 and 2817 differentially expressed
gene (DEG) features when FO-fed fish were compared to WCO-
and ECO-fed fish, respectively, with 849 probes common between
both contrasts (Fig. 1A). The common DEG were subjected to more
detailed analysis by assigning them KO numbers and mapping them
to a known compendium of metabolic pathways (KEGG). The
pathways commonly affected in both contrasts were those related
to cell communication (68% of genes in common), circulatory
system (67%), xenobiotic degradation and metabolism (61%) and
lipid metabolism (56%) (Fig. 1B). When the list was reduced to the
top 100 differentially expressed features, the main category affected
was metabolism (70.4%), particularly lipid (59.3%) followed by
carbohydrate (5.6%) metabolism (Supplementary Table 2). The
high representation of lipid metabolism was partly due to some
genes being represented by several features, particularly those
related to fatty acid desaturation (delta-6 and 5 fatty acyl
desaturase) and cholesterol metabolism (isopentenyl-diphosphate
delta isomerase).
The metabolic response in liver of fish fed ECO was more similar
to that in fish fedWCOcompared to fish fed FO. Statistical analysis
of the microarray data returned a list of 2817 and 1361 DEG in liver
of salmon fed ECO were compared to fish fed FO or WCO
respectively, (p , 0.05; Fig. 2A). From these transcripts, 2389 were
exclusive to the ECO v. FO comparison (p, 0.05), of which 747were
regulated at a fold change (FC) . 1.5 (31.3% of the total number of
transcripts) (Fig. 2B). When comparing liver from salmon fed ECO
with WCO, 933 probes exclusive to this contrast were identified, of
which 319 had a FC. 1.5 (34.2%) (Figs. 2A and 2B). A total of 428
transcripts were ECO specific (common to both contrasts, Fig. 2A)
and, of these, only 9 showed expression changes in opposite
directions (ECO/FO and ECO/WCO), indicating that the
transcriptomic response was consistent. After removing non-
annotated genes, KEGG analysis of the common 428 transcripts
returned 148 KO terms at p , 0.05 and revealed that the most
affected biological categories were metabolism (32%), translation
(17%) and transcription (13%) (Fig. 2C). More comprehensive
analysis of the top 100 most significant hits and fold differences
showed increased representation of metabolism, and particularly
lipid metabolism (Supplementary Table 3). The differing distri-
bution was mainly due to the repetition of multiple features of
isopentenyl-diphosphate delta isomerase (idi) gene and to the lower
significances found in the other categories. The high fold-changes
(FC) found in the lipid metabolism category were noteworthy,
especially when comparing ECO-fed fish to to FO-fed fish, with an
average FC of 24.14 for idi, 24.69 for farnesyl pyrophosphate
synthetase (fdps) or 24.95 for squalene epoxidase (sqle), all genes
involved in cholesterol/isoprenoid biosynthesis. Carbohydrate
metabolism category was also augmented and it is remarkable the
high FC (26.18) in the ECO/FO contrast of theMGC80816 protein,
involved in butanoate metabolism. Other categories affected were
translation (16.7%), transport (6.3%), protein folding (4.2%),
signalling (4.2%), transcription (2.1%) and digestive system (2.1%).
The microarray analyses data were fully validated by qPCR of
selected genes. Validation of the microarray data was performed
by comparing the expression of 10 genes, selected according to
their significant up- or down-regulation including some belonging
to the LC-PUFA biosynthesis pathway that were identified by KEGG
analysis as being significantly affected by diet (Table 6). Good
correspondence in terms of intensity (FC) and direction of change
(up- or down-regulation) was observed among the studied genes
(90%, 9 out of 10). However, the match was less consistent in
terms of significance (p value) when comparing microarray and
qPCR results which could be due to the relatively small changes in
expression observed in all the genes for both analyses.
No transgenic EPA-Camelina DNA fragments could be detected
in liver, pyloric caeca or muscle. All salmon tissues tested negative
for the presence of the Camelina T-DNA gene construct, as
monitored by the use of nptII primers, directed towards the
transgene construct sequence, whereas all tissues tested positive to
salmon growth hormone gene, gh (Fig. 3).
Discussion
Inclusion of the EPA-rich Camelina oil in diets for juvenile Atlantic
salmon had no detrimental effects on fish growth or performance
after seven weeks of feeding the experimental diets. Furthermore,
performance did not differ between fish fed any of the three diets,
confirming that the oil from transgenic Camelina could be employed
as a replacement for fish oil in feeds for Atlantic salmon. The fish
Table 5 | Lipid content (percentage of wet weight) and fatty acid
compositions (percentage of total fatty acids) of total lipid from liver
of Atlantic salmon after 7 weeks of feeding the experimental diets
FO WCO ECO
Lipid content 3.6 6 0.1c 5.9 6 0.8a 4.2 6 0.2b
14:0 2.1 6 0.1a 1.3 6 0.1b 1.1 6 0.1b
16:0 18.7 6 0.9a 11.0 6 1.7c 14.1 6 0.8b
18:0 4.9 6 0.4 4.8 6 0.1 5.7 6 0.1
20:0 0.1 6 0.0c 0.4 6 0.0b 0.5 6 0.0a
Total saturated1 26.3 60.5a 17.8 6 1.6c 21.6 6 0.9b
16:1n-7 2.7 6 0.2a 1.8 6 0.1b 1.5 6 0.0b
18:1n-9 10.5 6 1.1b 22.0 6 2.8a 11.8 6 0.5b
18:1n-7 2.7 6 0.2a 2.2 6 0.0b 1.9 6 0.1c
20:1n-11 0.1 6 0.0 0.1 6 0.0 0.1 6 0.0
20:1n-9 1.2 6 0.1b 5.9 6 0.9a 2.0 6 0.3b
20:1n-7 0.2 6 0.0b 0.2 6 0.0a 0.2 6 0.0b
22:1n-11 0.4 6 0.1 0.5 6 0.1 0.4 6 0.0
22:1n-9 0.1 6 0.0b 0.6 6 0.1a 0.2 6 0.0b
Total monoenes2 19.3 6 1.7b 34.4 6 4.0a 19.2 6 0.8b
18:2n-6 2.9 6 0.4c 10.8 6 0.8a 8.2 6 0.7b
18:3n-6 0.0 6 0.0c 0.4 6 0.0a 0.3 6 0.0b
20:2n-6 0.5 6 0.1b 1.8 6 0.1a 1.6 6 0.2a
20:3n-6 0.2 6 0.1b 1.3 6 0.1a 1.3 6 0.0a
20:4n-6 3.1 6 0.3b 1.1 6 0.3c 4.1 6 0.2a
Total n-6 PUFA3 7.3 6 0.4b 15.5 6 0.5a 15.8 6 0.7a
18:3n-3 1.0 6 0.2c 9.1 6 0.8a 3.9 6 0.5b
18:4n-3 0.3 6 0.1c 1.7 6 0.1a 0.6 6 0.0b
20:3n-3 0.2 6 0.0c 1.2 6 0.1a 0.8 6 0.1b
20:4n-3 0.9 6 0.1b 2.1 6 0.2a 1.9 6 0.1a
20:5n-3 9.8 6 0.2b 4.1 6 0.7c 10.9 6 0.2a
22:5n-3 3.3 6 0.1b 1.1 6 0.2c 4.3 6 0.2a
22:6n-3 31.5 6 1.9a 12.8 6 2.8c 20.9 6 1.6b
Total n-3 PUFA4 46.9 6 1.6a 32.2 6 2.9b 43.2 6 0.6a
Total PUFA 54.4 6 1.2b 47.8 6 2.5c 59.1 6 0.1a
Total n-3LC-PUFA 45.5 6 2.0a 20.1 6 3.6c 38.0 6 1.2b
Data expressed as means 6 SD (n 5 3). Different superscript letters within a row denote significant
differences among diets. Statistical differences were determined by one-way ANOVA with Tukey’s
comparison test (p , 0.05).
1contains 15:0, 22:0 and 24:0;
2contains 16:1n-9 and 24:1n-9;
3contains 22:4n-6 and 22:5n-6;
4contains C16 PUFA. ECO, feed containing oil from transgenic Camelina; FO, fish oil feed; LC-
PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3);
WCO, feed containing oil from wild-type Camelina.
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performance data obtainedwere consistent with those reported prev-
iously in other feeding trials where fish oil was substituted by equi-
valent wild-type Camelina oil in juvenile Atlantic cod (Gadus
morhua)32 and Atlantic salmon33. In contrast, cod fed a diet formu-
lated with defatted fishmeal and regular (wild-type) Camelina oil
displayed lower weight gain than fish fed non-defatted fishmeal
together with regular CO due to the requirements for essential fatty
acids (n-3 LC-PUFA) not beingmet by the former diet34. It should be
noted, therefore, that in this present trial, growth performance was
not impacted in WCO-fed fish because the feeds were formulated
with non-defatted fishmeal that contained sufficient n-3 LC-PUFA
to satisfy salmon essential fatty acids (EFA) requirements17. This was
as planned, as the present trial was specifically designed to investigate
the effectiveness of the oil from transgenic Camelina (Tr-CO) in
supplying high levels of n-3 LC-PUFA (in this case EPA), well in
excess of EFA requirement levels, so that the dietary n-3 LC-PUFA
would be largely deposited and stored by the fish.
Therefore, it is important to stress that n-3 LC-PUFA in fish
feeds can be defined at three levels17. Firstly, the minimum level
required to satisfy EFA requirements and thus prevent deficiency
signs35. This level is low (,1% of diet for salmonids species) and
relatively easy to supply even with today’s current high demand
for fish oil16. The second level is that required to sustain max-
imum growth and optimum health in fish being fed modern high-
energy diets17. It is largely unknown in most fish species and,
although higher than the minimum level, it is still relatively low.
The third level, and the subject of the present study, is the level we
must provide to ensure that the nutritional quality of farmed fish
is maintained such that it contains n-3 LC-PUFA at similar or
higher levels than can be found in wild fish. This dietary level far
exceeds the biological requirements of the fish itself and cannot
currently be met without the use of high levels of marine fish oil
and fishmeal in the feeds, but ultimately reflects the expectations
of consumer and their perception of fish such as salmon as health-
beneficial.
In addition to its effectiveness as a substitute for dietary fish oil, the
Tr-CO represented a high-EPA/zero DHA oil that has been hitherto
unavailable and so presents unique oil with which to study n-3 LC-
PUFAmetabolism, including EPA to DHA pathways, in vertebrates.
In this respect, several interesting results were obtained using this
EPA-only oil. The utilisation of dietary vegetable oils has been assoc-
iated with increased lipid deposition in fish tissues32–33,36–37. Results
Figure 1 | Impact of diet on liver transcriptome of Atlantic salmon given feeds containing Camelina oils (ECO andWCO) in comparison with fish fed
fish oil (FO). (A) Venn diagram representing mRNA transcripts differentially expressed in the liver of Atlantic salmon fed the experimental diets WCO
and ECO compared to diet FO. The area of the circles is scaled to the number of transcripts (Welch t-test, p, 0.05). (B) Distribution by categories of
common differentially expressed genes (428) in liver between Atlantic salmon fedWCOand ECOwhen compared to FO-fed fish (Welch t-test, p, 0.05).
Non-annotated genes and features corresponding to the same gene are not represented.
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from the present study supported this, as whole fish and liver lipid
content was higher in fish fed both ECO and WCO than in fish fed
FO. The reduced dietary n-3 LC-PUFA, that are known to suppress
TAG accumulation in mammalian pre-adipocytes38 or lipid accu-
mulation in Atlantic salmon adipocytes39, may be the mechanism
for the increased lipid deposition in fish fed vegetable oils. Indeed,
fish fedWCO showed increased levels of TAG, which is in agreement
with previous studies32,34. However, fish fed the ECO diet had similar
liver n-3 PUFA levels (other than DHA) as FO-fed fish, and showed
increased hepatic lipid levels, which could indicate that the factor
determining the increased adiposity could be reduced DHA levels,
rather than overall n-3 PUFA levels.
The ECO diet had differing effects on fatty acid deposition
depending on tissue. As expected of a tissue that serves as a
lipid/energy store in salmon, muscle largely reflected dietary fatty
acid composition15. Higher levels of desaturation products of
18:3n-3 and 18:2n-6 observed in muscle of ECO-fed fish com-
pared to WCO-fed fish probably reflected the higher dietary con-
tent of these fatty acids rather than active biosynthesis.
Nonetheless, limited activation of the LC-PUFA biosynthesis
pathway was observed in fish fed WCO as shown by increased
18:4n-3 compared to fish fed FO. Increased elongation products of
18:3n-3 and 18:2n-6, 20:3n-3 and 20:2n-6, observed in fish fed
both ECO and WCO compared to fish fed FO were consistent
with data from many studies that report an increase in these
elongation products after feeding vegetable oils in fish spe-
cies32,40–42. Inhibition of this elongation may be another example
of a DHA effect that dietary EPA alone cannot replicate.
Importantly though, muscle DHA did not vary between fish fed
the ECO or WCO diets and, although its level was higher than
that found in those diets, this was likely due to selective retention
Figure 2 | Impact of diet on liver transcriptome of Atlantic salmon given a feed containing oil from transgenic Camelina (ECO) in comparison
with fish given feeds containing fish oil (FO) or wild-type Camelina oil (WCO). (A) Venn diagram representing mRNA transcripts differentially
expressed in the liver of Atlantic salmon fed the ECO diet compared to fish fed the WCO and FO diets. The area of the circles is scaled to the number of
transcripts (Welch t-test, p, 0.05). (B) Numbers of DEG ranked by fold-change and direction of change, up- or down, in fish fed ECO compared to fish
fed FOorWCO (C)Distribution by categories of common differentially expressed genes (428) in liver between Atlantic salmon fed ECO compared to fish
fed FO and WCO (Welch t-test, p , 0.05). Non-annotated genes and features corresponding to the same gene are not represented.
Table 6 | Validation of microarray results by qPCR
Liver
Microarray qPCR
FC p FC p
fads2d6 12.65 0.001 13.07 0.001
fads2d5 12.91 0.002 13.96 0.021
elovl2 11.55 0.010 11.69 0.267
elovl5a 11.51 0.014 11.13 0.716
elovl5b 11.47 0.020 11.29 0.688
palld 11.18 0.006 11.19 0.763
ap1m2 11.36 0.010 11.28 0.817
arsb 21.71 0.000 11.11 0.516
litaf 11.52 0.043 11.04 0.404
g3bp 11.84 0.040 11.34 0.883
Data shown are the fold-changes (FC) between expression levels in fish fed diets FO and ECO and
p value (assessed by REST 2009).fads2d6, delta-6 fatty acyl desaturase; fads2d5, delta-5 fatty acyl
desaturase; elovl2, fatty acyl elongase 2; elovl5a, fatty acyl elongase 5 isoform a; elovl5b, fatty
acyl elongase isoform b; palld, pallidin; ap1m2, AP-1 complex subunit mu-2; arsb, arysulfatase B;
litaf, lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog; g3bp, galectin-3-
binding protein.
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of DHA reported previously in many studies where salmon were
fed dietary vegetable oil33,43–44. Most importantly, from a human
health viewpoint, the ECO-fed salmon would have more beneficial
effects compared to WCO-fed fish due to total n-3 LC-PUFA
content in muscle being nearly twice that in fish fed WCO, albeit
not as high as in fish fed FO.
In contrast tomuscle, liver exhibited active LC-PUFA biosynthesis
in fish fed the ECO diet, with higher DHA levels than those found in
fish fed WCO. These results were supported by up - regulation of
fads2d6, fads2d5 and elovl2 gene expression in the liver of fish fed
ECO, as expected for the operation of the LC-PUFA biosynthesis
pathway in salmonids including the Sprecher shunt45. These genes
were up-regulated in Atlantic salmon juveniles fed a vegetable oil
enriched with EPA, whereas, the inclusion of EPA plus DHA inhib-
ited their expression46. The results in the present study indicate that
the relative lack of dietary DHA in diets ECO and WCO induced
expression of the enzymes involved in its biosynthesis, and that high
dietary EPA (as in ECO) did not reduce their expression.
Interestingly, production of shorter chain products derived from
18:3n-3, such as 18:4n-3, 20:3n-3 and 20:4n-3, were not observed
in the liver of ECO-fed fish. In contrast, WCO-fed fish that also
displayed up-regulated expression of fads2d6, fads2d5 and elovl2,
show increased levels of 18:4n-3, 20:3n-3 and 20:4n-3. The lower
level of these intermediates in fish fed ECO is likely due to the high
concentration of EPA found in liver, which would compete with
18:3n-3 at the level of fads2d6.
Dietary impacts on metabolism were determined by investigating
the transcriptome of liver as the main organ integrating, processing
and distributing dietary lipid47. Several studies analysing fish tran-
scriptomic responses after substitution of dietary fish oil with veget-
able oils have shown that, regardless of oil employed,metabolism and
in particular lipid metabolism, are highly affected categories47–51 For
instance, genes involved in LC-PUFA biosynthesis were overrepre-
sented among theDEG in liver of Atlantic salmon fed vegetable oils47.
In the present study, this applies to fish fed both WCO and ECO
diets, where these genes occupy the top positions among the 100
highest expressed genes in terms of intensity, when compared to fish
fed FO. Another metabolic pathway significantly affected by dietary
vegetable oil was sterol metabolism. Vegetable oils are both low in
cholesterol and can also be rich in phytosterols, which have been
shown to reduce plasma cholesterol, LDL-cholesterol and LDL-TAG
in brook trout (Salvelinus fontinalis)52 and LDL-cholesterol in
humans by inhibiting intestinal cholesterol intake53. It was also evid-
ent that the ECO feed affected pathways related to carbohydrate
metabolism, which represented 10% of the common DEG between
the ECO/FO and ECO/WCO contrasts. Alteration of this category is
not surprising, as pathways of lipogenesis, lipolysis, glycolysis, glu-
coneogenesis and pentose phosphate shunt are interrelated in
Atlantic salmon48 and thus, alterations in lipid metabolism may also
affect carbohydrate metabolism.
In conclusion, genetically engineered Camelina has proved to be a
feasible source of n-3 LC-PUFAwhich could effectively substitute for
FO in aquafeeds and provide levels of these important fatty acids in
farmed fish that could maintain their nutritional quality for the
human consumer. The oil investigated in the present study, charac-
terised by the presence of 20% EPA, was entirely suitable for feeding
Atlantic salmon. It maintained the nutritional quality of the fillet, as
high levels of EPA and also DPA, both highly beneficial for human
health, were accumulated. Furthermore, increased levels of DPA and
DHA were accumulated in the liver, accompanied by an increase in
the expression of the enzymes involved in the endogenous biosyn-
thesis of LC-PUFA.Moreover, this high-EPA/zeroDHAoil triggered
ametabolic response similar to that generated by wild-type Camelina
oil, mainly affecting lipidmetabolism pathways, which indicated that
a combination of EPA and DHA confers the metabolic properties of
FO rather than EPA alone.
Methods
Metabolic engineering of Camelina. A construct containing a cassette of five genes
was used for transformation30. Briefly, the five-gene construct contained a set of genes
optimised for EPA synthesis: a D6-desaturase gene fromOstreococcus tauri (OtD6), a
D6 fatty acid elongase gene from Physcomitrella patens (PSE1), a D5-desaturase gene
from Thraustochytrium sp. (TcD5), a D12-desaturase gene from Phytophthora sojae
(PsD12) and an v3-desaturase from Phytophthora infestans (Pi- v3) as described in
detail previously30. All genes were individually cloned under the control of seed-
specific promoters, and then combined into a single T-DNA transformation vector as
described previously28. The destination vector contained an NPTII gene with the nos
promoter as a selectionmarker. All open reading frames for desaturases and elongases
were re-synthesised and codon-optimised for expression in C. sativa.
Production of Camelina oil. C. sativa was grown in a controlled-environment
chamber at 23uC day/18uC night, 50–60% humidity, and kept under a 16 h
photoperiod (long day) at 250 mmol m22 sec21. Oil (7 kg) was produced from seeds
(approximately 20 kg) by cold-pressing and solvent extraction to maximise yield
(,35%) (PPM, Magdeburg, Germany). The anti-oxidant ethoxyquin was added to
stabilise the final product.
Diets and feeding trial. Three isonitrogenous and isoenergetic diets were formulated
to satisfy the nutritional requirements of salmonid fish (Supplementary Table 4)17.
The diets supplied 46 g.kg21 crude protein and 21 g.kg21 crude lipid at a crude energy
level of 22.5 MJ.kg21 and were manufactured at BioMar Tech-Centre (Brande,
Denmark). The three feeds were produced by vacuum coating identical dry basal
extruded pellets with either fish oil (FO), wild-type Camelina oil (WCO) or EPA-
Camelina oil (ECO) (Supplementary Table 4). Non-defatted fishmeal was employed
as the major protein source to ensure EFA requirements were met17. A total of 405
juvenile (post-smolt) Atlantic salmon with an average body weight of 82.5 6 8.1 g
(mean6 S.D.) were distributed between 9 seawater tanks (45 per tank) and fed one of
the three experimental feeds in triplicate for 7 weeks. Prior to the start of the
experimental period fish were fed a standard commercial feed containing 30% fish oil
and 70% rapeseed oil. The experimental system comprised 1 m2, 500 L tanks supplied
by flow-through seawater (15 L min21) at ambient temperature that averaged 10.2 6
0.6uC. Experimental feeds were delivered in excess by automatic disc feeders with an
automated uneaten feed collection system in order to determine accurate feed
efficiency. At the end of the trial fish were weighed and growth rate, feed efficiency
and biometric parameters calculated as follows: Specific growth rate (SGR) 5 100 *
(lnWf – lnWo)/t, where Wo 5 initial weight (g) and Wf 5 final weight (g) at time t
(days). Feed conversion ratio (FCR) 5 FI/(Bf - Bo), where FI 5 feed intake (g), Bo 5
initial biomass (g) and Bf 5 final biomass (g). Fulton’s condition factor (k) 5 100 *
(W/L3), whereW is the final weight (g) and L is the total length (cm). Liver and empty
gastrointestinal tract were used to calculate hepatosomatic index (HSI)5 liver weight
(g) * 100/Wf (g) and viscerosomatic index (VSI) 5 liver 1 gastrointestinal tract (g) *
100/Wf (g).
Figure 3 | Cropped gel showing PCR products from liver (a), pyloric
caeca (b) andmuscle/flesh (c) of Atlantic salmon fed eitherWCO or ECO
diets for nptII (transgenesis marker; top image) or gh (fish gene, bottom
image). All the gels were run under the same experimental conditions.
Lanes 1–6, Atlantic salmon fed WCO diet; Lanes 7–12, Atlantic salmon
fed ECO diet; EPA-Camelina, transgenic Camelina seed cake; M,marker;
NTC, non template control.
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Sample collection. At the end of the trial, fish were not fed for 48 h prior to being
anaesthetised and killed by overdose with metacaine sulphonate (MS222). Three
whole fish per tank (9 per treatment) were frozen for analyses of proximate
composition. A further 9 fish per tank were used for biometric measurements
(hepato-somatic and viscera-somatic indices) and tissue analyses. Samples of flesh
(Norwegian quality cut; NQC) and liver from 3 fish per tank were immediately frozen
in liquid nitrogen and stored at 270 oC prior to total lipid and fatty acid analyses.
Further samples of liver were collected from six fish per treatment (two per tank) and
stabilised in RNAlaterH (Sigma, Poole, UK) prior to RNA extraction.
Proximate composition. Diets and whole fish were ground before determination of
proximate composition according to standard procedures54. Fish were pooled per
tank and three technical replicates for single batch diet were analysed. Moisture
contents were obtained after drying in an oven at 110uC for 24 h and ash content
determined after incineration at 600uC for 16 h. Crude protein content wasmeasured
by determining nitrogen content (N 3 6.25) using automated Kjeldahl analysis
(Tecator Kjeltec Auto 1030 analyzer, Foss, Warrington, UK) and crude lipid content
determined gravimetrically after Soxhlet lipid extraction (Tecator Soxtec system 2050
Auto Extraction apparatus).
Lipid class and fatty acid compositions. Samples of muscle (flesh) and liver from
three fish per tank were prepared as pooled homogenates and total lipid extracted
from 1 g by homogenising in chloroform/methanol (251, v/v) using an Ultra-Turrax
tissue disrupter (Fisher Scientific, Loughborough, UK), and content determined
gravimetrically55. Lipid classes were separated by double-development, high-
performance thin-layer chromatography (HPTLC)56. Total lipid samples (1–2 mg)
were applied and the plates developed in methyl acetate/isopropanol/chloroform/
methanol/0.25% aqueous KCl (2552552551059, by vol.). Excess solvent was
evaporated via air drying and vacuum desiccation and plates developed to 9.5 cm
using a solvent mixture containing isohexane/diethyl ether/acetic acid (8052051, by
vol.). Lipid classes were visualised by spraying with 3% (w/v) aqueous cupric acetate
containing 8% (v/v) phosphoric acid and charring plates at 160uC for 20 min. Lipid
classes were quantified by densitometry using a CAMAG-3 TLC scanner (version
Firmware 1.14.16; CAMAG,Muttenz, Switzerland). Fatty acid methyl esters (FAME)
were prepared from total lipid by acid-catalysed transesterification at 50uC for 16 h57,
using heptadecanoic acid (17:0) as an internal standard. FAME were extracted and
purified as described previously57. FAMEwere separated and quantified by gas-liquid
chromatography using a Fisons GC-8160 (Thermo Scientific, Milan, Italy) equipped
with a 30 m 3 0.32 mm i.d. 3 0.25 mm ZB-wax column (Phenomenex, Cheshire,
UK), on-column injector and a flame ionization detector. Data were collected and
processed using Chromcard for Windows (version 2.01; Thermoquest Italia S.p.A.,
Milan, Italy). Individual FAME were identified by comparison to known standards
and published data58.
RNA extraction. Liver from six individual fish per dietary treatment were
homogenised in 1 ml of TriReagentH (Sigma-Aldrich, Dorset, UK) RNA extraction
buffer using a bead tissue disruptor (Bio Spec, Bartlesville, Oklahoma, USA). Total
RNA was isolated following manufacturer’s instructions and quantity and quality
determined by spectrophotometry using a Nanodrop ND-1000 (Labtech Int., East
Sussex, UK) and electrophoresis using 500 ng of total RNA in a 1% agarose gel.
Microarray hybridisations and image analysis. Transcriptome analysis was
performed in liver tissues using an Atlantic salmon custom-made oligoarray with
44 k features per array on a four-array-per-slide format (Agilent Technologies UK
Ltd., Wokingham, UK). The probes were co-designed by researchers at the Institute
of Aquaculture (University of Stirling, UK) and the Norwegian Institute of Food,
Fisheries and Aquaculture Research (Nofima, Tromsø, Norway). A dual-label
experimental design was employed for the microarray hybridisations with Cy3-
labelled test samples competitively hybridised to a common Cy5-labelled pooled-
reference per array. A total of 36 arrays were utilised, one array per individual fish and
tissue. The common reference was a pool of equal amounts of amplified RNA from all
test samples.
Indirect labelling methodology was employed in preparing the microarray targets.
Amplified antisense RNA (aRNA) was produced from each RNA sample using
TargetAmpTM 1-Round Aminoallyl-aRNA Amplification Kit 101 (Epicentre,
Madison, Wisconsin, USA), as per manufacturer’s methodology, followed by Cy3 or
Cy5 fluor incorporation through a dye-coupling reaction. Microarray hybridisations
were performed in SureHyb hybridisation chambers in a DNA Microarray
Hybridisation Oven (Agilent Technologies). For each hybridisation, 825 ng of Cy3-
labelled experimental biological replicate and Cy5-labelled reference pool were
combined and total volume made up to 35 ml with nuclease-free water. Detailed
information regarding the microarray hybridisations and image analysis has been
published previously48.
Quantitative real time PCR. Expression of candidate genes of interest (fatty acyl
desaturases 5 and 6 and fatty acyl elongases 2, 5a and 5b) was determined by
quantitative PCR (qPCR) in liver from fish fed all diets, as well as genes formicroarray
validation (Supplementary Table 5). Results were normalised using reference genes,
elongation factor 1-a and cofilin-2, which were chosen as themost stable according to
GeNorm. cDNA was synthesised using 2 mg of total RNA and random primers in
20 ml reactions and the High capacity reverse transcription kit without RNase
inhibiter according to themanufacturer’s protocol (Applied Biosystems,Warrington,
UK). The resulting cDNAwas diluted 20-fold with milliQ water. The efficiency of the
primers for each gene was previously evaluated to ensure that it was close to 100%.
qPCR was performed using a Biometra TOptical Thermocycler (Analytik Jena,
Goettingen, Germany) in 96-well plates in duplicate 20 ml reaction volumes
containing 10 ml of SYBR Green RT-PCR Master Mix (Applied Biosystems), 1 ml of
the primer corresponding to the analyzed gene (10 pmol), 3 ml of molecular biology
grade water and 5 ml of cDNA, with the exception of the reference genes, which were
determined using 2 ml of cDNA. In addition amplifications were carried out with a
systematic negative control (NTC-non template control) containing no cDNA.
Standard amplification parameters contained an initial activation step at 95uC for
15 min, followed by 35 cycles: 15 s at 95uC, 30 s at the annealing Tmand 30 s at 72uC.
Tracking of the nptII gene in Atlantic salmon liver, pyloric caeca and muscle.
Genomic DNA was extracted from fish flesh, pyloric caeca and liver using
REALPURE extraction kit (Valencia, Spain) according to the manufacturer’s
instructions. Briefly, tissue samples were incubated in 300 ml of lysis solution
overnight at 55uC with 3 ml of Proteinase K. Following the incubation, samples were
cooled down and RNase treatment performed (37uC for 60 min). After protein
precipitation, DNA was precipitated by adding 300 ml of isopropanol and hydrated
with 5 mM Tris. Total DNA was quantified by spectrophotometry and quality
determined by electrophoresis as described above. Two primers pairs targeting an
endogenous Atlantic salmon gene (growth hormone) and a transgene marker
(Kanamycin resistance gene, nptII) were used (Supplementary Table 5). Fifty ng of
extracted DNA was used in PCR amplifications which were performed in a final
volume of 10 ml, containing 5 ml ofMyTaqTMHSMix (Bioline, London, UK). Each set
of PCR included a positive control (DNA from EPA-Camelina) and a non-template
control (NTC).
Statistical analysis. All data are means 6 S.E. (n 5 3) unless otherwise specified.
Percentage data for survival, proximate composition, lipid content and fatty acid
composition were subjected to arcsin square-root transformation prior to
statistical analyses. Data were tested for normality and homogeneity of variances
with Levene’s test prior to one-way analysis of variance followed by a Tukey-
Kramer HSD multiple comparisons of means. All statistical analyses were
performed using SPSS software (IBM SPSS Statistics 19; SPSS Inc., Chicago, IL,
USA). Statistical analysis of microarray hybridization data was performed in
GeneSpring GX version 12.6.1 (Agilent Technologies, Wokingham, Berkshire,
UK) using a Welch (unpaired unequal variance) t-test, at 0.05 significance. No
multiple test correction was employed as previous analyses indicated that they
were over-conservative for these nutritional data48,49. Data were submitted to the
Kyoto Encyclopedia of Genes and Genomes (KEGG) for biological function
analysis. Gene expression results were analyzed using the relative expression
software tool (REST 2009), which employs a pairwise fixed reallocation
randomization test (10,000 randomizations) with efficiency correction59 to
determine the statistical significance of expression ratios (gene expression fold
changes) between two treatments.
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